An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...

When I went to the hospital last year for my annual mammogram, I expected to be in and out in 60 minutes. Being a healthy ...

From April, women invited for a routine breast cancer screening will be invited to take part in the trial at 30 testing sites across the country. The AIs will be tested to see how well they can assist ...

Following a broad FDA approval for the adjuvant treatment of HR-positive, HER2-negative early breast cancer in September, Novartis’ Kisqali grew U.S. sales by 65% year over year—or nearly 25% ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel anxious and overwhelmed.

"Just as with inflammatory bowel disease, we know the earlier you find out about cancer, the better. "Anything that enables early detection with quicker, less invasive diagnostic tests, removing ...

A diagnosis of metastatic breast cancer can be overwhelming, and one of the many challenges it brings can be social isolation. It's OK to be alone sometimes, and it can even be restorative. However, ...